Home Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother
Article
Licensed
Unlicensed Requires Authentication

Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother

  • Elpis-Athina Vlachopapadopoulou EMAIL logo , Eirini Dikaiakou , Anatoli Fotiadou , Popi Sifianou , Elizabeth Barbara Tatsi , Amalia Sertedaki , Christina Kanaka-Gantenbein and Stefanos Michalacos
Published/Copyright: October 8, 2020

Abstract

Objectives

Congenital Hyperinsulinism (CHI) is the most common cause of persistent hypoketotic hypoglycaemia in neonates and infants. It is a genetic disorder with both familial and sporadic forms.

Case Presentation

In this study, we examined two unrelated infants of diabetic mothers (IDMs) presented with HH. DNA sequencing (Sanger and NGS panel) identified pathogenic variants of the Hepatocyte Nuclear Factor 4A (HNF4A) gene in both families. Pathogenic variants of HNF4A gene are reported to cause HH in the newborn period and Maturity Onset Diabetes of the Young (MODY) later in life. The diagnosis of MODY was made in retrospect for the two mothers, thus improving the management of their diabetes.

Conclusion

Genetic testing for CHI is strongly recommended if neonatal hypoglycemia persists. A family history of MODY or presumed type II diabetes can support that the affected gene is HNF4A.


Corresponding author: Dr. Elpis Vlachopapadopoulou, MD, Department of Endocrinology, Growth and Development, “P. & A. Kyriakou” Children’s Hospital, Athens, Greece, Phone: +302132009851, Fax: +302132009531, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The authors have no conflict of interest to disclose, and no other funding or financial relationship.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Gϋemes, M, Rahman, SA, Kapoor, RR, Flanagan, S, Houghton, JAL, Misra, S, et al. Hyperinsulinemic hypoglycemia in children and adolescents: recent advances in understanding of pathophysiology and management. Rev Endocr Metab Disord 2020. https://doi.org/10.1007/s11154-020-09548-7. In press.Search in Google Scholar PubMed PubMed Central

2. Arnoux, JB, Verkarre, V, Saint-Martin, C, Montravers, F, Brassier, A, Valayannopoulos, V, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 2011 Oct 3;6:63. https://doi.org/10.1186/1750-1172-6-63.Search in Google Scholar PubMed PubMed Central

3. Männistö, JME, Maria, M, Raivo, J, Kuulasmaa, T, Otonkoski, T, Huopio, H, et al. Clinical and genetic characterization of 153 patients with persistent or transient congenital hyperinsulinism. J Clin Endocrinol Metab 2020 Apr 1;105. https://doi.org/10.1210/clinem/dgz271.Search in Google Scholar PubMed

4. Warncke, K, Kummer, S, Raile, K, Grulich-Henn, J, Woelfle, J, Steichen, E, et al. Frequency and characteristics of MODY 1 (HNF4A mutation) and MODY 5 (HNF1B mutation): analysis from the DPV database. J Clin Endocrinol Metab 2019 Mar 1;104:845–55. https://doi.org/10.1210/jc.2018-01696.Search in Google Scholar PubMed

5. Demirbilek, H, Hussain, K. Congenital hyperinsulinism: diagnosis and treatment update. J Clin Res Pediatr Endocrinol 2017 Dec 30;9:69–87. https://doi.org/10.4274/jcrpe.2017.S007.Search in Google Scholar PubMed PubMed Central

6. Thornton, PS, Stanley, CA, De Leon, DD, Harris, D, Haymond, MW, Hussain, K, et al. Recommendations from the Pediatric Endocrine Society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr 2015;167:238–45. https://doi.org/10.1016/j.jpeds.2015.03.057.Search in Google Scholar PubMed

7. Minakova, E, Chu, A. Congenital hyperinsulinism. Pediatr Ann 2017 Nov 1;46:e409–e14. https://doi.org/10.3928/19382359-20171020-01.Search in Google Scholar PubMed

8. Pearson, ER, Boj, SF, Steele, AM, Barrett, T, Stals, K, Shield, JP, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007 Apr;4:e118. https://doi.org/10.1371/journal.pmed.0040118.Search in Google Scholar PubMed PubMed Central

9. Huerta-Saenz, L, Saunders, C, Yan, Y. Challenging diagnosis of congenital hyperinsulinism in two infants of diabetic mothers with rare pathogenic KCNJ11 and HNF4A gene variants. Int J Pediatr Endocrinol 2018; 2018: 5. https://doi.org/10.1186/s13633-018-0060-7.Search in Google Scholar PubMed PubMed Central

10. Mark J. Lachmann, Burak Salgin, Sebastian Kummer, Alena Welters, Carsten Döing, Martin Zenker, et al. Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations. J Pediatr Endocrinol Metabol 2016;29:281–7.https://doi.org/10.1515/jpem-2015-0192.Search in Google Scholar PubMed

Received: 2020-05-22
Accepted: 2020-08-30
Published Online: 2020-10-08
Published in Print: 2021-04-27

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum
  4. PATRO children, a multi-center, non-interventional study of the safety and effectiveness of Omnitrope® (somatropin) treatment in children: update on the United States cohort
  5. Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study
  6. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification
  7. Ultrasonographic determination of thyroid volume in infants and children from Aegean region of Turkey and comparison with national and international references
  8. Association of thyroid autoimmunity and the response to recombinant human growth hormone in Turner syndrome
  9. Evaluating transition in Turner syndrome in the West of Scotland
  10. Short-term effects of gonadotropin-releasing hormone analogue treatment on leptin, ghrelin and peptide YY in girls with central precocious puberty
  11. Metabolic syndrome and risk factors after hematopoietic stem cell transplantation in children and adolescents
  12. Urinary bisphenol A levels in prepubertal children with exogenous obesity according to presence of metabolic syndrome
  13. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study
  14. Incidence of diabetes in children and adolescents in Dhaka, Bangladesh
  15. Case Reports
  16. False-positive very long-chain fatty acids in a case of autoimmune adrenal insufficiency
  17. Prepubescent unilateral gynecomastia secondary to excessive soy consumption
  18. Detection of hepatocyte nuclear factor 4A(HNF4A) gene variant as the cause for congenital hyperinsulinism leads to revision of the diagnosis of the mother
  19. Coexistence of dyschondrosteosis associated to SHOX deficiency, pseudohypoparathyroidism 1B, and chronic autoimmune thyroiditis: a case report
Downloaded on 17.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0302/html
Scroll to top button